Latest News & Updates
Breaking News
6 hours ago
Vaibhavi M.
Other trending news you may like to read
Perspective Initiates Early-Stage Study Of FAP-α Targeted Radiopharmaceutical In Cancer Patients
Perspective Therapeutics begins Phase 1/2a trial, dosing first patient with [212Pb]PSV359 to evaluate safety and efficacy in FAP-α solid tumours.
Vaibhavi M.
Merck Launches Wilmington Biotech Hub To Manufacture KEYTRUDA®, Creating Jobs And Advancing U.S. Biologics Manufacturing
Merck launched a $1B biologics centre in Delaware, which is set to produce KEYTRUDA and next-gen therapies, creating 500+ jobs.
Vaibhavi M.
.png)
AbbVie’s RINVOQ Receives FDA Approval For Treatment Of Giant Cell Arteritis In Adults
AbbVie receives FDA approval for RINVOQ in GCA, supported by intense Phase 3 results showing higher sustained remission vs. placebo.
Vaibhavi M.
.png)
AbbVie’s RINVOQ Receives FDA Approval For Treatment Of Giant Cell Arteritis In Adults
AbbVie receives FDA approval for RINVOQ in GCA, supported by intense Phase 3 results showing higher sustained remission vs. placebo.
Vaibhavi M.
